G Model
CCLET-6170; No. of Pages 5
X. Wang, H. Lin, J. Liu et al.
Chinese Chemical Letters xxx (xxxx) xxx–xxx
and Phe424. The overall binding mode of HPPA is quite like the
binding modes of these three inhibitors, except that HPPA phenyl
ring only forms a T-
p stacking against the phenyl sidechain of
Phe381. The minimum substructures of these HPPD inhibitors
mimic the α-keto acid moiety of HPPA. The orientation of their
aromatic rings resembles the HPPA phenyl ring. The QM/MM
calculations combined with QM calculations predict that the free
energy change for the binding of dioxygen to the iron is only
-1.5 kcal/mol, suggesting a very weak negative binding affinity
between them. As illustrated in previous section (Fig. 3), the phenyl
ring will block the further association of dioxygen to the ketone
carbon, hence the bound HPPA will behave like an inhibitor due to
the failure of associating the O2. The aromatic rings of the HPPD
inhibitors show similar shape and orientation to the HPPA phenyl
ring. Following the story of the latter, these aromatic rings will also
repel the association of dioxygen to the adjacent ketone carbons.
Thus, these inhibitors exert their roles by preventing the addition
of O2 and suppressing the oxidation of the active site metal ion.
This inference is supported by the experimental observation that
the HPPD does not bind O2 in the presence of its inhibitors.
In our experiments on the conversion reaction of HPPA
catalyzed by AtHPPD, significant substrate-inhibition effect was
Fig. 4. Relative energy profile and geometries of the stationary points for the
dioxygen addition step in F398A mutant. The total charge and multiplicity for the
QM region are set to be
0 and quintet, respectively. The relative energy is
determined at the B3LYP/6-311++G(2d,2p):AMBER level.
phenyl ring may also affect the shape of potential energy profile for
the reaction of the bound dioxygen with the α-KG group. Free
energy barrier and free energy change for this step are respectively
calculated to be 18.8 and -40.3 kcal/mol, demonstrating that the
dioxygen will readily be associated with the substrate HPPA.
It is necessary to address the role of the residue Phe381 during
the catalysis in order to characterize the HPPD-HPPA complex
observed in the crystal. Kinetic experiments [12] showed that the
also observed with Ksi =226.0 mmol/L and Km =44.4 mmol/L (see
Supporting information for details). The inhibition constants (Ki) of
NTBC [28], sulcotrione and Y13508 against HPPD were reported to
be 6.43, 5.79 and 1.30 nmol/L, respectively. These data imply that
HPPA binds to HPPD with different conformations. Some
conformations lead to the reaction product HGA or the intermedi-
ate HPA. Some others do not react with HPPD leading to substrate
self-inhibition. In this study, we prove that the substrate
conformation observed in the AtHPPD-HPPA crystal structure is
an inactive form, which contributes to the substrate self-inhibition
of HPPD.
Km for F381A mutant was 9.1
mmol/L, whereas the one for the
wild-type HPPD was 1.9 mol/L. The F381A mutant had similar kcat
m
(0.92 sÀ1) to that of the wild-type (1.08 sÀ1). These data suggest
that Phe381 may not directly participate the catalytic reaction.
Hence, HPPA observed in the crystal structure should be a
temporary intermediate during the substate transportations,
instead of the previously assumed pre-reactive configuration. As
HPPA is transported into pre-reactive configuration, it will be
readily converted to HGA and released to the environment, leaving
an empty catalytic pocket. As evidenced by the crystal structure
reporting the bound HPPA (Fig. S11 in Supporting information),
three out of four subunits are vacant, implying that most
conversion reactions in these places have completed. The present
study demonstrates that the HPPA binding mode observed in the
crystal structure is not the reactive mode. Despite various binding
modes advanced so far, more proofs are still needed to validate
them. So far, it is still an open question for the determine the
reactive binding mode of HPPA.
Declaration of competing interest
The authors report no declarations of interest.
Acknowledgments
The work was supported by the National Key R&D Program (No.
2018YFD0200100) and National Natural Science Foundation of
China (Nos. 21837001, 21273089 and 22007035, U20A2038), the
Open Project Fund of the Key Laboratory of the Pesticides and
Chemical Biology of Central China Normal University (No. 2018-
A01), the Fundamental Research Funds for the South-Central
University for Nationalities (No. CZW20020), the Fundamental
Research Funds for the Central Universities (No. KJ02072020-
0657), and Hubei Province Natural Science Foundation (No.
2020CFB487).
It is interesting to compare the HPPA binding mode in this study
to the ones of known HPPD inhibitors [28] NTBC (PDB ID: 5CTO),
sulcotrione (PDB ID: 5YWG) and Y13508 according to the crystal
structures (Fig. 5). For each inhibitor in Fig. 5, two carbonyl groups
form chelation interaction with the ferrous ion and its aromatic
ring forms a
p-p stacking interaction with side chains of Phe381
Appendix A. Supplementary data
Supplementarymaterialrelatedtothisarticlecanbefound, inthe
References
[1] N.P. Crouch, M.H. Lee, T. Iturriagagoitia-Bueno, et al., Cloning, Expression, and
Purification of Mammalian 4-Hydroxyphenylpyruvate Dioxygenase/α-
Ketoisocaproate Dioxygenase, Academic Press, Salt Lake City, 2000.
[2] M. Kohlmeier, Amino Acids and Nitrogen Compounds, Academic Press, San
Diego, 2015.
[3] H. Ahrens, G. Lange, T. Muller, et al., Angew. Chem. Int. Ed. Eng. 52 (2013) 9388–
9398.
[4] R. Beaudegnies, A.J. Edmunds, T.E. Fraser, et al., Bioorg. Med. Chem. 17 (2009)
4134–4152.
Fig. 5. Binding modes of the HPPA (yellow scheme), Y13508 (green scheme), NTBC
[5] D.W. Wang, H.Y. Lin, B. He, et al., J. Agric. Food Chem. 64 (2016) 8986–8993.
(blue scheme) and sulcotrione (pink scheme) in the catalytic site of HPPD.
4